Form 4: Astera Labs CEO Jitendra Mohan Sells Shares Under 10b5-1 Trading Plan

Astera Labs CEO Jitendra Mohan sold shares of the company's common stock on October 11, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On October 11, 2024, Jitendra Mohan, the CEO of Astera Labs, Inc. sold shares of the company's common stock.
• The sales were executed automatically under a Rule 10b5-1 trading plan adopted on May 31, 2024.
• A total of 47,667 shares were sold at a weighted average price of $70.2581 per share.
• The shares were sold in multiple transactions with prices ranging from $70.0000 to $70.6900.
• Following the transactions, Mohan continues to beneficially own a significant number of shares both directly and indirectly through various trusts.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine disclosure of stock sales under a pre-arranged trading plan. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The impact on the stock price is usually minimal unless the sales are unusually large or frequent.

Comparison to Industry Standards

• Insider sales are a common occurrence in publicly traded companies, and the use of 10b5-1 plans is a standard practice to ensure compliance with securities laws.
• Comparable companies like Marvell, Broadcom, and Nvidia also see regular Form 4 filings from their executives.
• The size of the sale (47,667 shares) is relatively small compared to the total outstanding shares of Astera Labs, suggesting it's unlikely to have a significant impact on the stock price.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, but it's unlikely to be significant given the relatively small size of the transaction and the use of a 10b5-1 trading plan.

Key Dates